← Open Payments lookup

JENNA VEGA: Open Payments

NPI 1609418375 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,244 in 43 payments from 7 companies in 2025. Trend: 2023 $1,452 · 2024 $645 · 2025 $1,244

Food & beverage: $1,244
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$342
E.R. Squibb & Sons, L.L.C.17$282
Teva Pharmaceuticals USA, Inc.5$216
Alkermes, Inc.5$203
Otsuka America Pharmaceutical, Inc.3$145
Lundbeck LLC2$40
Luye Pharma (USA) Ltd.1$15

Products named: INGREZZA, COBENFY, UZEDY, LYBALVI, ABILIFY MAINTENA, ARISTADA, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE.

Industry payments across LA — which companies pay providers there.